Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunityDaniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 6, 2023
Real-World Sensitization and Tolerance Pattern to Seafood in Fish-Allergic IndividualsAgnes S Y Leung, Christine Y Y Wai, Nicki Y H Leung, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2025
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 1, 2021
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2024
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consentDouglas P Mack, Timothy E Dribin, Paul J Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty VaccinationGilbert T Chua, Mike Yat Wah Kwan, Celine S L Chui, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
JAMA Network Open|May 3, 2021
Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong KongGilbert T Chua, Joshua Sung Chih Wong, Ivan Lam, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Deborah Albright, Sara Anvari, et al.
Pageof 21